amoxicillin-clavulanate oral suspension 600 mg-42.9 mg/5 mL
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for amoxicillin-clavulanate oral suspension 600 mg-42.9 mg/5 mL, covering 2008-10-23 to 2008-10-23. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg-42.9 mg/ 5 mL Oral Suspension Under Fed Conditions [NA]